Supplementary Table S1 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation Article Swipe
Aditi Dhir
,
Masanori Hayashi
,
Avery Bodlak
,
Javier Oesterheld
,
David M. Loeb
,
Leo Mascarenhas
,
Michael S. Isakoff
,
Eric Sandler
,
Scott C. Borinstein
,
Matteo Trucco
,
Joanne Lagmay
,
Bhuvana A. Setty
,
Christine A. Pratilas
,
Emi Caywood
,
Jonathan Metts
,
Hong Yin
,
Brooke L. Fridley
,
Jun Yin
,
José Laborde
,
Damon R. Reed
,
Daniel L. Adams
,
Lars M. Wagner
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.27938167
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.27938167
Supplementary Table S1. Representativeness of Study Participants
Related Topics
Concepts
Metadata
- Type
- supplementary-materials
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.27938167
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4404934063
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4404934063Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.27938167Digital Object Identifier
- Title
-
Supplementary Table S1 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer FoundationWork title
- Type
-
supplementary-materialsOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-02Full publication date if available
- Authors
-
Aditi Dhir, Masanori Hayashi, Avery Bodlak, Javier Oesterheld, David M. Loeb, Leo Mascarenhas, Michael S. Isakoff, Eric Sandler, Scott C. Borinstein, Matteo Trucco, Joanne Lagmay, Bhuvana A. Setty, Christine A. Pratilas, Emi Caywood, Jonathan Metts, Hong Yin, Brooke L. Fridley, Jun Yin, José Laborde, Damon R. Reed, Daniel L. Adams, Lars M. WagnerList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.27938167Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/1078-0432.27938167Direct OA link when available
- Concepts
-
Gemcitabine, Medicine, Nab-paclitaxel, Paclitaxel, Osteosarcoma, Oncology, Cancer, Biopsy, Foundation (evidence), Liquid biopsy, Internal medicine, Radiology, Pathology, History, ArchaeologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4404934063 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.27938167 |
| ids.doi | https://doi.org/10.1158/1078-0432.27938167 |
| ids.openalex | https://openalex.org/W4404934063 |
| fwci | 0.0 |
| type | supplementary-materials |
| title | Supplementary Table S1 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10253 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9984999895095825 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Sarcoma Diagnosis and Treatment |
| topics[1].id | https://openalex.org/T11845 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.994700014591217 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Cancer therapeutics and mechanisms |
| topics[2].id | https://openalex.org/T12226 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9886999726295471 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Neuroblastoma Research and Treatments |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780258809 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8538717031478882 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q414143 |
| concepts[0].display_name | Gemcitabine |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.7460826635360718 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2910430875 |
| concepts[2].level | 4 |
| concepts[2].score | 0.6822636723518372 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q7251413 |
| concepts[2].display_name | Nab-paclitaxel |
| concepts[3].id | https://openalex.org/C2777292972 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6630243062973022 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q423762 |
| concepts[3].display_name | Paclitaxel |
| concepts[4].id | https://openalex.org/C2777760704 |
| concepts[4].level | 2 |
| concepts[4].score | 0.541601836681366 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q549534 |
| concepts[4].display_name | Osteosarcoma |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.5205434560775757 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C121608353 |
| concepts[6].level | 2 |
| concepts[6].score | 0.48544198274612427 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[6].display_name | Cancer |
| concepts[7].id | https://openalex.org/C2775934546 |
| concepts[7].level | 2 |
| concepts[7].score | 0.48428720235824585 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q179991 |
| concepts[7].display_name | Biopsy |
| concepts[8].id | https://openalex.org/C2780966255 |
| concepts[8].level | 2 |
| concepts[8].score | 0.47866925597190857 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q5474306 |
| concepts[8].display_name | Foundation (evidence) |
| concepts[9].id | https://openalex.org/C2779529041 |
| concepts[9].level | 3 |
| concepts[9].score | 0.4468270540237427 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q22349364 |
| concepts[9].display_name | Liquid biopsy |
| concepts[10].id | https://openalex.org/C126322002 |
| concepts[10].level | 1 |
| concepts[10].score | 0.4089178740978241 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[10].display_name | Internal medicine |
| concepts[11].id | https://openalex.org/C126838900 |
| concepts[11].level | 1 |
| concepts[11].score | 0.3851885497570038 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q77604 |
| concepts[11].display_name | Radiology |
| concepts[12].id | https://openalex.org/C142724271 |
| concepts[12].level | 1 |
| concepts[12].score | 0.16434860229492188 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[12].display_name | Pathology |
| concepts[13].id | https://openalex.org/C95457728 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q309 |
| concepts[13].display_name | History |
| concepts[14].id | https://openalex.org/C166957645 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q23498 |
| concepts[14].display_name | Archaeology |
| keywords[0].id | https://openalex.org/keywords/gemcitabine |
| keywords[0].score | 0.8538717031478882 |
| keywords[0].display_name | Gemcitabine |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.7460826635360718 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/nab-paclitaxel |
| keywords[2].score | 0.6822636723518372 |
| keywords[2].display_name | Nab-paclitaxel |
| keywords[3].id | https://openalex.org/keywords/paclitaxel |
| keywords[3].score | 0.6630243062973022 |
| keywords[3].display_name | Paclitaxel |
| keywords[4].id | https://openalex.org/keywords/osteosarcoma |
| keywords[4].score | 0.541601836681366 |
| keywords[4].display_name | Osteosarcoma |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.5205434560775757 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/cancer |
| keywords[6].score | 0.48544198274612427 |
| keywords[6].display_name | Cancer |
| keywords[7].id | https://openalex.org/keywords/biopsy |
| keywords[7].score | 0.48428720235824585 |
| keywords[7].display_name | Biopsy |
| keywords[8].id | https://openalex.org/keywords/foundation |
| keywords[8].score | 0.47866925597190857 |
| keywords[8].display_name | Foundation (evidence) |
| keywords[9].id | https://openalex.org/keywords/liquid-biopsy |
| keywords[9].score | 0.4468270540237427 |
| keywords[9].display_name | Liquid biopsy |
| keywords[10].id | https://openalex.org/keywords/internal-medicine |
| keywords[10].score | 0.4089178740978241 |
| keywords[10].display_name | Internal medicine |
| keywords[11].id | https://openalex.org/keywords/radiology |
| keywords[11].score | 0.3851885497570038 |
| keywords[11].display_name | Radiology |
| keywords[12].id | https://openalex.org/keywords/pathology |
| keywords[12].score | 0.16434860229492188 |
| keywords[12].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.27938167 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.27938167 |
| locations[1].id | pmh:oai:figshare.com:article/27938167 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Phase_II_Trial_of_Gemcitabine_and_Nab-Paclitaxel_for_Recurrent_Osteosarcoma_with_Serial_Monitoring_Using_Liquid_Biopsy_A_Report_from_the_National_Pediatric_Cancer_Foundation/27938167 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5032461485 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9974-0073 |
| authorships[0].author.display_name | Aditi Dhir |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Aditi Dhir |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5045599016 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-9508-0159 |
| authorships[1].author.display_name | Masanori Hayashi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Masanori Hayashi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5063933814 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9207-1532 |
| authorships[2].author.display_name | Avery Bodlak |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Avery Bodlak |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5066731966 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2035-8977 |
| authorships[3].author.display_name | Javier Oesterheld |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Javier Oesterheld |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5034420962 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-7319-5000 |
| authorships[4].author.display_name | David M. Loeb |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | David M. Loeb |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5071801742 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7790-0777 |
| authorships[5].author.display_name | Leo Mascarenhas |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Leo Mascarenhas |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5028526364 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-4790-9919 |
| authorships[6].author.display_name | Michael S. Isakoff |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Michael S. Isakoff |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5012160886 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-0083-9370 |
| authorships[7].author.display_name | Eric Sandler |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Eric S. Sandler |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5078492954 |
| authorships[8].author.orcid | https://orcid.org/0000-0002-1721-1520 |
| authorships[8].author.display_name | Scott C. Borinstein |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Scott C. Borinstein |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5111352089 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | Matteo Trucco |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Matteo Trucco |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5046927078 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Joanne Lagmay |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Joanne P. Lagmay |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5081920235 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6054-817X |
| authorships[11].author.display_name | Bhuvana A. Setty |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Bhuvana A. Setty |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5075174884 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-7116-0605 |
| authorships[12].author.display_name | Christine A. Pratilas |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Christine A. Pratilas |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5027997230 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-2873-6058 |
| authorships[13].author.display_name | Emi Caywood |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Emi Caywood |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5002985161 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-1068-7857 |
| authorships[14].author.display_name | Jonathan Metts |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Jonathan Metts |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5100892465 |
| authorships[15].author.orcid | https://orcid.org/0000-0002-8184-113X |
| authorships[15].author.display_name | Hong Yin |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Hong Yin |
| authorships[15].is_corresponding | False |
| authorships[16].author.id | https://openalex.org/A5004055647 |
| authorships[16].author.orcid | https://orcid.org/0000-0001-7739-7956 |
| authorships[16].author.display_name | Brooke L. Fridley |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Brooke Fridley |
| authorships[16].is_corresponding | False |
| authorships[17].author.id | https://openalex.org/A5101473205 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-3242-9664 |
| authorships[17].author.display_name | Jun Yin |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Jun Yin |
| authorships[17].is_corresponding | False |
| authorships[18].author.id | https://openalex.org/A5079091439 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-2003-9653 |
| authorships[18].author.display_name | José Laborde |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Jose Laborde |
| authorships[18].is_corresponding | False |
| authorships[19].author.id | https://openalex.org/A5029966550 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-8238-2465 |
| authorships[19].author.display_name | Damon R. Reed |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Damon R. Reed |
| authorships[19].is_corresponding | False |
| authorships[20].author.id | https://openalex.org/A5005317276 |
| authorships[20].author.orcid | https://orcid.org/0000-0002-1916-9637 |
| authorships[20].author.display_name | Daniel L. Adams |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Daniel L. Adams |
| authorships[20].is_corresponding | False |
| authorships[21].author.id | https://openalex.org/A5058782198 |
| authorships[21].author.orcid | https://orcid.org/0000-0003-4717-9960 |
| authorships[21].author.display_name | Lars M. Wagner |
| authorships[21].author_position | last |
| authorships[21].raw_author_name | Lars M. Wagner |
| authorships[21].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/1078-0432.27938167 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Table S1 from Phase II Trial of Gemcitabine and Nab-Paclitaxel for Recurrent Osteosarcoma with Serial Monitoring Using Liquid Biopsy: A Report from the National Pediatric Cancer Foundation |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10253 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9984999895095825 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Sarcoma Diagnosis and Treatment |
| related_works | https://openalex.org/W2386730332, https://openalex.org/W2052188532, https://openalex.org/W4387660185, https://openalex.org/W4285524750, https://openalex.org/W4361918085, https://openalex.org/W2963236396, https://openalex.org/W4404893994, https://openalex.org/W4386272098, https://openalex.org/W1530886505, https://openalex.org/W4283026191 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/1078-0432.27938167 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.27938167 |
| primary_location.id | doi:10.1158/1078-0432.27938167 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.27938167 |
| publication_date | 2024-12-02 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index.of | 4 |
| abstract_inverted_index.S1. | 2 |
| abstract_inverted_index.Study | 5 |
| abstract_inverted_index.Table | 1 |
| abstract_inverted_index.Representativeness | 3 |
| abstract_inverted_index.<p>Supplementary | 0 |
| abstract_inverted_index.Participants</p> | 6 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 22 |
| citation_normalized_percentile.value | 0.44561103 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |